Search For "astrazeneca"
AstraZeneca's signs MoU with Indian Diabetes Research Society (RSS
Updated : 59 min ago IST
Bangalore (Karnataka) [India], November 26 (ANI/PRNewswire): AstraZeneca India (AstraZeneca Pharma India Limited), a leading science-led biopharmaceutical company, today signed a memorandum of understanding with the Research Society for Study of Diabetes in India (RSSDI).
Read More
Philippines logs 1,392 new COVID-19 cases, plans to buy 2 million
Updated : 4 hours, 34 min ago IST
Manila [The Philipines], November 26 (ANI/Xinhua): The Department of Health (DOH) of the Philippines on Thursday reported 1,392 new confirmed cases of COVID-19 infection, bringing the total number in the country to 424,297.
Read More
AZD1222 vaccine met primary efficacy endpoint in preventing COVID-
Updated : 3 days, 5 hours ago IST
New Delhi [India], November 23 (ANI): With an efficacy of around 90 per cent positive results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil the vaccine has proved to be highly effective in preventing COVID-19, said AstraZeneca on Monday.
Read More
Production of AstraZeneca COVID-19 vaccine begins in Australia
Updated : 2 weeks, 3 days ago IST
Canberra [Australia], November 9 (ANI/Sputnik): The CSL Limited company started production of the University of Oxford/AstraZeneca coronavirus vaccine on Monday, Australian media report.
Read More
AstraZeneca misses target for delivery of COVID-19 vaccine: UK Gov
Updated : 3 weeks ago IST
London [UK], November 5 (ANI/Sputnik): The pharmaceutical giant AstraZeneca has missed its target of delivering 30 million doses of its vaccine against COVID-19 to the UK by September, as the producer is predicted to only hand over 4 million doses by the end of the year, Kate Bingham, the he
Read More
AstraZeneca resumes US COVID-19 vaccine trial
Updated : 1 month ago IST
London [UK], October 24 (ANI): The clinical trials for the AstraZeneca Oxford coronavirus vaccine -- AZD1222 -- have resumed in the United States after approval by the Food and Drug Administration (FDA), the company said on Friday (local time).
Read More
Brazil's COVID-19 vaccine volunteer dies, authorities say trial
Updated : 1 month ago IST
Brasilia [Brazil], October 22 (ANI): A volunteer in Brazil's clinical trial of COVID-19 vaccine being developed by AstraZeneca and Oxford University has died, the Brazilian health agency Anvisa announced on Wednesday while adding that the trial will continue.
Read More
Trudeau announces vaccine pact as Canada surpasses 150,000 Covid c
Updated : 2 months ago IST
Toronto [Canada], September 26 (ANI/Sputnik): Canadian Prime Minister Justin Trudeau on Friday announced that his government has entered into an agreement with British pharmaceutical giant AstraZeneca to procure 20 million doses of its coronavirus vaccine.
Read More
Serum Institute all set to begin phase 3 trials of Covid-19 vaccin
Updated : 2 months, 1 week ago IST
Pune (Maharashtra) [India], September 19 (ANI): Serum Institute of India (SII) is all set to begin phase three trials of the Covishield Vaccine developed by AstraZeneca and Oxford University at Sassoon General Hospital in Pune, the hospital administration said on Saturday.
Read More
DCGI gives nod to Serum Institute to restart phase 2,3 trials for
Updated : 2 months, 1 week ago IST
New Delhi [India], September 16 (ANI): The Drugs Controller General of India (DCGI) has allowed Serum Institute of India (SII) to restart its phase two and three clinical trials for COVID-19 vaccine after the pharma major submitted the recommendations of the Data Safety Monitoring Board (DSM
Read More
Equity indices trade higher, IT stocks shine
Updated : 2 months, 1 week ago IST
Mumbai (Maharashtra) [India], September 14 (ANI): Equity benchmark indices traded firm during early hours on Monday on the back of positive global cues as hopes of a coronavirus vaccine were rekindled after AstraZeneca resumed its phase three trial.
Read More
Suspension of AstraZeneca COVID-19 vaccine trials showed fallacy o
Updated : 2 months, 2 weeks ago IST
Moscow [Russia], September 13 (ANI): Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev on Saturday said that temporary suspension of AstraZeneca COVID-19 vaccine candidate trials clearly showed the "fallacy of the approach" when countries "exclusively rely on novel and untested platf
Read More